UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in Japan

Cephalalgia, 2023-05, Vol.43 (5), p.3331024231177649-3331024231177649

2023

Volltextzugriff (PDF)

Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan

Frontiers in neurology, 2023-07, Vol.14, p.1220285-1220285

2023

Volltextzugriff (PDF)

Investigating the relationships between the burden of multiple sensory hypersensitivity symptoms and headache-related disability in patents with migraine

Journal of headache and pain, 2021-12, Vol.22 (1), p.77-77, Article 77

2021

Volltextzugriff (PDF)

Parietal Cheiro-oral Syndrome

Internal Medicine, 2020/04/15, Vol.59(8), pp.1115-1115

2020

Volltextzugriff (PDF)

Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study

Journal of headache and pain, 2021-06, Vol.22 (1), p.53-53, Article 53

2021

Volltextzugriff (PDF)

Central sensitization in migraine is related to restless legs syndrome

Journal of neurology, 2021-04, Vol.268 (4), p.1395-1401

2021

Volltextzugriff (PDF)

Evaluating the wearing-off effects of fremanezumab in high-frequency episodic migraine and chronic migraine: A real-world observational study in Japan

Cephalalgia reports, 2023-01, Vol.6

2023

Volltextzugriff (PDF)

Exploring the contributing factors to multiple chemical sensitivity in patients with migraine

Journal of occupational health, 2022-01, Vol.64 (1), p.e12328-n/a

2022

Volltextzugriff (PDF)

Factors contributing to sleep disturbances and excessive daytime sleepiness in patients with Parkinson's disease

Frontiers in neurology, 2023-03, Vol.14, p.1097251-1097251

2023

Volltextzugriff (PDF)

Sleep and Autonomic Manifestations in Parkinson's Disease Complicated With Probable Rapid Eye Movement Sleep Behavior Disorder

Frontiers in neuroscience, 2022-04, Vol.16, p.874349-874349

2022

Volltextzugriff (PDF)

Real-world effectiveness of erenumab in Japanese patients with migraine

Heliyon, 2024-02, Vol.10 (4), p.e26568-e26568, Article e26568

2024

Volltextzugriff (PDF)

Can calcitonin gene-related peptide monoclonal antibody improve migraine and restless legs syndrome?

Journal of the neurological sciences, 2022-12, Vol.443, p.120462-120462, Article 120462

2022

Volltextzugriff (PDF)

Bilateral hippocampal hyperintensities on diffusion‐weighted images in transient global amnesia

Neurology and clinical neuroscience, 2016-09, Vol.4 (5), p.197-197

2016

Volltextzugriff (PDF)

Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study

Journal of neurology, 2023-09, Vol.270 (9), p.4377-4384

2023

Volltextzugriff (PDF)

Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule

Journal of the neurological sciences, 2023-12, Vol.455, p.122786-122786, Article 122786

2023

Volltextzugriff (PDF)

Impact of diabetes and glycated hemoglobin level on the clinical manifestations of Parkinson's disease

Journal of the neurological sciences, 2023-11, Vol.454, p.120851-120851, Article 120851

2023

Volltextzugriff (PDF)

Restless legs syndrome and its variants in acute ischemic stroke

Acta neurologica Scandinavica, 2019-03, Vol.139 (3), p.260-268

2019

Volltextzugriff (PDF)

Impact of autonomic symptoms on the clinical course of Parkinson’s disease

Neurological sciences, 2024-08, Vol.45 (8), p.3799-3807

2024

Volltextzugriff (PDF)

V180I genetic Creutzfeldt-Jakob disease with cardiac sympathetic nerve denervation masquerading as Parkinson's disease: A case report

Medicine (Baltimore), 2021-01, Vol.100 (2), p.e24294-e24294

2021

Volltextzugriff (PDF)

Central Sensitization in Migraine: A Narrative Review

Journal of Pain Research, 2022-01, Vol.15, p.2673-2682

2022

Volltextzugriff (PDF)

Parietal Cheiro-oral Syndrome

Internal Medicine, 2020, pp.3964-19

2020

Volltextzugriff (PDF)

Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson’s Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture

Journal of Parkinson's disease, 2021-01, Vol.11 (3), p.1047-1056

2021

Volltextzugriff (PDF)

Adult-onset Alexander disease mimicking multiple system atrophy predominant cerebellar ataxia

Journal of clinical neuroscience, 2021-05, Vol.87, p.150-152

2021

Volltextzugriff (PDF)

Quality of life of patients with Parkinson's disease and their caregivers during the COVID-19 pandemic

Journal of the neurological sciences, 2021-10, Vol.429, p.119542-119542, Article 119542

2021

Volltextzugriff (PDF)

Series: Diagnosis at a Glance

Nihon Naika Gakkai zasshi, 2021-05, Vol.110 (5), p.1017-1019

2021

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(46)
Mit Volltextzugriff
(52)

Publikationsform

Sprache

Englisch
(58)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Effectiveness of three calcitonin gene-related peptide monoclonal antibodies for migraine: A 12-month, single-center, observational real-world study in Japan

Real-world experience with monthly and quarterly dosing of fremanezumab for the treatment of patients with migraine in Japan

Investigating the relationships between the burden of multiple sensory hypersensitivity symptoms and headache-related disability in patents with migraine

Parietal Cheiro-oral Syndrome

Impact of the COVID-19 pandemic on migraine in Japan: a multicentre cross-sectional study

Central sensitization in migraine is related to restless legs syndrome

Evaluating the wearing-off effects of fremanezumab in high-frequency episodic migraine and chronic migraine: A real-world observational study in Japan

Exploring the contributing factors to multiple chemical sensitivity in patients with migraine

Factors contributing to sleep disturbances and excessive daytime sleepiness in patients with Parkinson's disease

Sleep and Autonomic Manifestations in Parkinson's Disease Complicated With Probable Rapid Eye Movement Sleep Behavior Disorder

Real-world effectiveness of erenumab in Japanese patients with migraine

Can calcitonin gene-related peptide monoclonal antibody improve migraine and restless legs syndrome?

Bilateral hippocampal hyperintensities on diffusion‐weighted images in transient global amnesia

Could efficacy at 1 week after galcanezumab administration for patients with migraine predict responders at 3 months? A real world study

Switching from calcitonin gene-related peptide monoclonal antibody monthly to fremanezumab quarterly based on the patient's preferred dosing schedule

Impact of diabetes and glycated hemoglobin level on the clinical manifestations of Parkinson's disease

Restless legs syndrome and its variants in acute ischemic stroke

Impact of autonomic symptoms on the clinical course of Parkinson’s disease

V180I genetic Creutzfeldt-Jakob disease with cardiac sympathetic nerve denervation masquerading as Parkinson's disease: A case report

Central Sensitization in Migraine: A Narrative Review

Parietal Cheiro-oral Syndrome

Impact of the COVID-19 Pandemic on the Quality of Life of Patients with Parkinson’s Disease and Their Caregivers: A Single-Center Survey in Tochigi Prefecture

Adult-onset Alexander disease mimicking multiple system atrophy predominant cerebellar ataxia

Quality of life of patients with Parkinson's disease and their caregivers during the COVID-19 pandemic

Series: Diagnosis at a Glance

Suchergebnisse filtern